| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 02/22/2007 | WO2007021034A1 Scavenger of harmful active oxygen and/or free radical in living body |
| 02/22/2007 | WO2007020917A1 Agent for enhancing and prolonging utrophin production and processed food comprising the same |
| 02/22/2007 | WO2007020888A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 02/22/2007 | WO2007019661A1 Supplemental dietary composition for enhancing muscle performance and/or recovery from fatigue |
| 02/22/2007 | CA2619769A1 Scavenger of in vivo harmful reactive oxygen species and/or free radicals |
| 02/22/2007 | CA2619545A1 Novel use of peptide compounds for treating muscle pain |
| 02/22/2007 | CA2618653A1 Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder |
| 02/21/2007 | EP1754476A1 Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia |
| 02/21/2007 | EP1753456A2 Methods for treating conditions associated with masp-2 dependent complement activation |
| 02/21/2007 | EP1519726B1 Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 02/21/2007 | CN1917894A Muscular tension-elevating agent |
| 02/20/2007 | US7179922 Chemical compounds |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179804 Tachykinin receptor antagonists |
| 02/19/2007 | CA2516745A1 Botulinum toxin in treatment of clubfoot relapse |
| 02/15/2007 | WO2007019417A1 Oxazolopyridine derivatives as sirtuin modulators |
| 02/15/2007 | WO2007019416A1 Benzimidazole derivatives as sirtuin modulators |
| 02/15/2007 | WO2007019346A1 Benzothiazoles and thiazolopyridines as sirtuin modulators |
| 02/15/2007 | WO2007019345A1 Imidazopyridine derivatives as sirtuin modulating agents |
| 02/15/2007 | WO2007019344A1 Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds |
| 02/15/2007 | WO2006009975A3 Histamine to treat disorders affecting muscle function |
| 02/15/2007 | US20070037996 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 02/15/2007 | US20070037995 A Substantially Cell Membrane Impermeable Compound And Use Thereof |
| 02/15/2007 | US20070037882 Remedy for cerebral neurodegenerative diseases using ppar agonist |
| 02/15/2007 | US20070037879 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/15/2007 | US20070037878 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/15/2007 | US20070037844 2-(1-Azabicyclo[2.2.2]oct-3-yl)-N-(7-bromo-1-benzothien-2-yl)acetamide hydrochloride; nicotinic receptor agonists; cognition activators; learning enhancement; nootropic agents; demetia; cholinergic agents; Alzheimer's disease; brain traumas; stroke; attention deficit disorder; schizophrenia |
| 02/15/2007 | US20070037772 Pyrazolidinol compounds |
| 02/15/2007 | US20070036854 Therapeutic applications of pro-apoptotic benzodiazepines |
| 02/15/2007 | US20070036768 Systems and methods for treating patients with processed lipoaspirate cells |
| 02/15/2007 | CA2618370A1 Oxazolopyridine derivatives as sirtuin modulators |
| 02/15/2007 | CA2618368A1 Imidazopyridine derivatives as sirtuin modulating agents |
| 02/15/2007 | CA2618360A1 Benzothiazoles and thiazolopyridines as sirtuin modulators |
| 02/15/2007 | CA2617557A1 Benzimidazole derivatives as sirtuin modulators |
| 02/15/2007 | CA2617532A1 Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds |
| 02/14/2007 | EP1750719A2 Treatment of diseases associated with altered level of amyloid beta peptides |
| 02/14/2007 | EP1534391B1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 02/14/2007 | EP1417228B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2007 | EP1379260B1 Methods for treating the inflammatory component of a brain disorder |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1343757B1 Indole derivatives |
| 02/14/2007 | EP1339701B1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 02/14/2007 | EP1280515B1 Pharmaceutical compositions comprising cannabis |
| 02/14/2007 | EP1126836B1 Benzamide potassium channel inhibitors |
| 02/14/2007 | EP1124959B1 Cell surface molecule-induced macrophage activation |
| 02/14/2007 | EP1009413B1 Use of immunostimulatory oligonucleotides for preventing or treating asthma |
| 02/14/2007 | CN1911965A Binding domain-immunoglobulin fusion proteins |
| 02/14/2007 | CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 02/14/2007 | CN1300116C 1H-indazole compound |
| 02/14/2007 | CN1299683C Celecoxib compositions |
| 02/13/2007 | US7176215 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 02/13/2007 | US7175850 Formulation for topical non-invasive application in vivo |
| 02/08/2007 | WO2007016676A1 Tizanidine compositions and methods of treatment using the compositions |
| 02/08/2007 | US20070032518 Compounds and methods of use |
| 02/08/2007 | US20070031443 Methods for treating or preventing skin disorders using CD2-binding agents |
| 02/08/2007 | CA2612480A1 Tizanidine compositions and methods of treatment using the compositions |
| 02/07/2007 | EP1749884A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 02/07/2007 | EP1749529A1 Utilisation of heteroarene carboxamide as dopamine-D3 ligands for the treatment of CNS diseases |
| 02/07/2007 | EP1749522A2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 02/07/2007 | EP1503765A4 Use of modulators of nicotinic receptors for treatment of cognitive dysfunction |
| 02/07/2007 | EP1401813B1 New indole derivatives with 5-ht6 receptor affinity |
| 02/07/2007 | CN1298707C Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 02/07/2007 | CN1298324C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (PDE4) inhibitors |
| 02/07/2007 | CN1298323C Fused pyrrolocarbazoles against inflammation |
| 02/07/2007 | CN1298314C Stable salts of O-acetylsalicylic acid containing basic amino acids II |
| 02/06/2007 | US7173047 Benzo (f) insoindol derivatives and their use as ep4 receptor ligands |
| 02/06/2007 | US7172769 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 02/06/2007 | CA2362816C Valdecoxib compositions |
| 02/01/2007 | WO2007014051A2 Use of amylin and amylin agonists as cardioprotective or myoprotective agents |
| 02/01/2007 | WO2007013691A1 Spiro-cyclic compound |
| 02/01/2007 | WO2006107826A3 Micro-rna's that regulate muscle cells |
| 02/01/2007 | WO2006091229A3 Methods of modulating intracellular degradation rates of toxins |
| 02/01/2007 | US20070027200 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 02/01/2007 | US20070027124 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 02/01/2007 | US20070027123 Administering an estrogen receptor for treatment of osteoporosis, breast cancer, hypercholesteremia, hyperlipidemia or artheriosclerosis by administering estrogen modulators |
| 02/01/2007 | US20070027122 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 02/01/2007 | US20070026036 Drug/Drug Delivery Systems for the Prevention and Treatment of Vascular Disease |
| 02/01/2007 | US20070026007 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 02/01/2007 | CA2617042A1 Spiro-cyclic compound |
| 02/01/2007 | CA2616395A1 B-cell reduction using cd37-specific and cd20-specific binding molecules |
| 01/31/2007 | EP1748069A1 Follistatin mutant polypeptide |
| 01/31/2007 | EP1747782A1 Products for topical application comprising lysophospholipids and fatty acids |
| 01/31/2007 | EP1747778A1 Antifatigue composition |
| 01/31/2007 | CN1906211A Novel muscle growth regulator |
| 01/31/2007 | CN1903349A Medicine composition for treating myasthenia gravis and prepn. method therefor |
| 01/31/2007 | CN1297548C Cyclic hemiacetal derivative and use thereof |
| 01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 01/30/2007 | US7169928 central nervous system disorders; Alzheimer's disease; attention deficit disorders; cognition activators; psychological disorders; antidepressants |
| 01/30/2007 | US7169899 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents |
| 01/30/2007 | US7169817 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 01/30/2007 | US7169798 Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases |
| 01/30/2007 | US7169782 Aryl substituted thiazolidinones and the use thereof |
| 01/30/2007 | US7169779 Inhibitors of p38 |
| 01/30/2007 | US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA |
| 01/30/2007 | US7169559 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 01/30/2007 | US7169389 Human CD154 binding molecules and treatment methods |
| 01/30/2007 | US7169387 Monoclonal antibodies orsoluble immunoglobulin fusion protein; block multiple sclerosis |
| 01/30/2007 | US7169378 Delivery of opioids through an inhalation route |